Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cognitive Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h Rivastigmine Patch in Severe Alzheimer's Disease: Severe Impairment Battery Factor Analysis
Aging, Dementia, and Behavioral Neurology
(-)
009
Authors/Disclosures
Steven Ferris
PRESENTER 		No disclosure on file
Robert L. Knobler, MD, PhD (Knobler Institute of Neurologic Disease, PC) No disclosure on file
Richard S. Isaacson, MD, FÂ鶹´«Ã½Ó³»­ Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Drew Velting, PhD (Novartis Pharmaceuticals Corp.) No disclosure on file
No disclosure on file